The Service Tree lists all services in "branched" groups, starting with the very general and moving to the very specific. Click on the name of any group name to see the sub-groups available within it. Click on a service code to see its details and the providers who offer that service.
Immunizations
Programs that inoculate susceptible individuals of all ages, but particularly people who are very young or very old, to prevent them from contracting any of the variant strains of influenza that are prevalent during the winter and spring. The vaccine may be administered as a "shot" that is given with a needle, usually in the arm, or in the form of a nasal mist.
Pneumococcal Pneumonia Immunizations
Programs that provide inoculations which protect susceptible people from contracting pneumococcal pneumonia. Vaccination is recommended for adults age 65 and older; persons with cardiovascular or pulmonary disorders including congestive heart failure, diabetes mellitus, chronic liver disease, alcoholism, CSF leaks, cardiomyopathy, COPD or emphysema; persons with splenic dysfunction or asplenia, hematologic malignancy, multiple myeloma, renal failure, organ transplantation or immunosuppressive conditions including HIV infections; and Alaskan Natives and certain Native American populations.
Programs that provide the Shingrix (recombinant zoster vaccine, or RZV) inoculations which prevent recipients from contracting shingles (herpes zoster). The vaccine is recommended for adults age 50 and older without contraindications, and adults 19 years and older who are immunocompromised. It is administered in a two dose schedule separated by two to six months. The vaccine cannot be used to treat the disease or post-herpetic neuralgia (pain after the rash is gone) once it develops, but can prevent future occurrences. The previously approved and used Zostavax vaccine is no longer available for use in the United States.
Programs that provide inoculations for adolescents and adults which protect them from contracting tetanus, diphtheria and/or pertussis (whooping cough) depending on which vaccines (Td or Tdap) are administered. Td is a tetanus-diphtheria vaccine given to adolescents and adults as a booster shot every 10 years, or after an exposure to tetanus under some circumstances. Tdap is similar to Td but also contains protection against pertussis; and can be given regardless of when Td was last received. Adolescents age 11-18 (preferably at the age of 11-12) and adults age 19 through 64 should receive a single dose of Tdap. Adults age 65 and older who have close contact with an infant and have not previously received Tdap, should also receive a single dose. Tdap should also be given to 7-10 year olds who are not fully immunized against pertussis. Inoculations are recommended for people in flooded areas who may be at risk of tetanus infections from dirty cuts, scrapes or puncture wounds.